VERONA, Italy, April 18, 2011 /PRNewswire/ -- On April 15th 2011, CROM, an established, full-service CRO headquartered in Verona (Italy), acquired MSOURCE, creating CROMSOURCE, a new CRO offering complete international coverage and a full range of clinical research services and staffing solutions.
After the excellent performance and the dramatic growth achieved in the last years, this acquisition is a further fundamental step in the CROM strategy to strengthen its position at an international level.
CROMSOURCE combines the capabilities and expertise of both MSOURCE and CROM and builds on the highly established infrastructure of CROM. Providing full international coverage, CROMSOURCE can now offer you an even greater level of experience and expertise in clinical operations in the field of pharmaceutical drug development and medical devices.
MSOURCE complements the CROM clinical research service portfolio by adding its well established clinical resourcing experience. Over recent years, the required complexity of drug and medical device development has increased, meaning that a full range of innovative and flexible development approaches are now necessary for success. CROMSOURCE is confident that because of its increased geographical coverage and service portfolio it can provide significant benefits and value to you.
CROMSOURCE will be led by Chief Executive Officer Oriana Zerbini, MD, the founder and owner of CROM. Frank van de Wijngaert, the former CEO of MSOURCE will leave CROMSOURCE on May 15th. "I am delighted to welcome the MSOURCE team to CROM and thank Frank for his dedication to MSOURCE" said Dr. Zerbini, "MSOURCE is a successful company in Western Europe in both clinical research and the growing area of clinical resourcing. Staffing solutions will be valuable as yet another service area for CROM, and with the geographical synergies in our established international infrastructure we provide significant benefits for our existing and new customers"
The new company, CROMSOURCE, will employ about 400 employees and generate over 50 Mio Euros of revenues.
In case of questions, please contact Margherita Mosconi at [email protected]